<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:08:42Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9070937" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9070937</identifier>
        <datestamp>2022-05-06</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS One</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9070937</article-id>
              <article-id pub-id-type="pmcid">PMC9070937</article-id>
              <article-id pub-id-type="pmc-uid">9070937</article-id>
              <article-id pub-id-type="pmid">35511858</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0267779</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-21-27220</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>People and Places</subject>
                  <subj-group>
                    <subject>Population Groupings</subject>
                    <subj-group>
                      <subject>Age Groups</subject>
                      <subj-group>
                        <subject>Adults</subject>
                        <subj-group>
                          <subject>Elderly</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Clinical Medicine</subject>
                    <subj-group>
                      <subject>Clinical Trials</subject>
                      <subj-group>
                        <subject>Randomized Controlled Trials</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Pharmacology</subject>
                    <subj-group>
                      <subject>Drug Research and Development</subject>
                      <subj-group>
                        <subject>Clinical Trials</subject>
                        <subj-group>
                          <subject>Randomized Controlled Trials</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Research and Analysis Methods</subject>
                  <subj-group>
                    <subject>Clinical Trials</subject>
                    <subj-group>
                      <subject>Randomized Controlled Trials</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Physiology</subject>
                    <subj-group>
                      <subject>Biological Locomotion</subject>
                      <subj-group>
                        <subject>Gait Analysis</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Public and Occupational Health</subject>
                    <subj-group>
                      <subject>Physical Activity</subject>
                      <subj-group>
                        <subject>Physical Fitness</subject>
                        <subj-group>
                          <subject>Exercise</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Sports and Exercise Medicine</subject>
                    <subj-group>
                      <subject>Exercise</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Sports Science</subject>
                    <subj-group>
                      <subject>Sports and Exercise Medicine</subject>
                      <subj-group>
                        <subject>Exercise</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Physiology</subject>
                    <subj-group>
                      <subject>Physiological Parameters</subject>
                      <subj-group>
                        <subject>Body Weight</subject>
                        <subj-group>
                          <subject>Obesity</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Anatomy</subject>
                    <subj-group>
                      <subject>Biological Tissue</subject>
                      <subj-group>
                        <subject>Connective Tissue</subject>
                        <subj-group>
                          <subject>Adipose Tissue</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Anatomy</subject>
                    <subj-group>
                      <subject>Biological Tissue</subject>
                      <subj-group>
                        <subject>Connective Tissue</subject>
                        <subj-group>
                          <subject>Adipose Tissue</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Pharmacology</subject>
                    <subj-group>
                      <subject>Drug Interactions</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Physiology</subject>
                    <subj-group>
                      <subject>Biological Locomotion</subject>
                      <subj-group>
                        <subject>Walking</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Estimating heterogeneity of physical function treatment response to caloric restriction among older adults with obesity</article-title>
                <alt-title alt-title-type="running-head">Heterogeneity of obesity treatment response</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4286-9463</contrib-id>
                  <name>
                    <surname>Beavers</surname>
                    <given-names>Daniel P.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="cor001" ref-type="corresp">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hsieh</surname>
                    <given-names>Katherine L.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kitzman</surname>
                    <given-names>Dalane W.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kritchevsky</surname>
                    <given-names>Stephen B.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Messier</surname>
                    <given-names>Stephen P.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Neiberg</surname>
                    <given-names>Rebecca H.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Nicklas</surname>
                    <given-names>Barbara J.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rejeski</surname>
                    <given-names>W. Jack</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Beavers</surname>
                    <given-names>Kristen M.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC, United States of America</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Section on Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States of America</addr-line>
              </aff>
              <aff id="aff003">
                <label>3</label>
                <addr-line>Section on Cardiovascular Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States of America</addr-line>
              </aff>
              <aff id="aff004">
                <label>4</label>
                <addr-line>Department of Health and Exercise Science, Wake Forest University, Winston-Salem, NC, United States of America</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Bello-Chavolla</surname>
                    <given-names>Omar Yaxmehen</given-names>
                  </name>
                  <role>Editor</role>
                  <xref rid="edit1" ref-type="aff"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>Instituto Nacional de Geriatria, MEXICO</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>dbeavers@wakehealth.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>5</day>
                <month>5</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2022</year>
              </pub-date>
              <volume>17</volume>
              <issue>5</issue>
              <elocation-id>e0267779</elocation-id>
              <history>
                <date date-type="received">
                  <day>22</day>
                  <month>8</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>14</day>
                  <month>4</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2022 Beavers et al</copyright-statement>
                <copyright-year>2022</copyright-year>
                <copyright-holder>Beavers et al</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0267779.pdf"/>
              <abstract>
                <p>Clinical trials conventionally test aggregate mean differences and assume homogeneous variances across treatment groups. However, significant response heterogeneity may exist. The purpose of this study was to model treatment response variability using gait speed change among older adults participating in caloric restriction (CR) trials. Eight randomized controlled trials (RCTs) with five- or six-month assessments were pooled, including 749 participants randomized to CR and 594 participants randomized to non-CR (NoCR). Statistical models compared means and variances by CR assignment and exercise assignment or select subgroups, testing for treatment differences and interactions for mean changes and standard deviations. Continuous equivalents of dichotomized variables were also fit. Models used a Bayesian framework, and posterior estimates were presented as means and 95% Bayesian credible intervals (BCI). At baseline, participants were 67.7 (SD = 5.4) years, 69.8% female, and 79.2% white, with a BMI of 33.9 (4.4) kg/m<sup>2</sup>. CR participants reduced body mass [CR: -7.7 (5.8) kg vs. NoCR: -0.9 (3.5) kg] and increased gait speed [CR: +0.10 (0.16) m/s vs. NoCR: +0.07 (0.15) m/s] more than NoCR participants. There were no treatment differences in gait speed change standard deviations [CR–NoCR: -0.002 m/s (95% BCI: -0.013, 0.009)]. Significant mean interactions between CR and exercise assignment [0.037 m/s (95% BCI: 0.004, 0.070)], BMI [0.034 m/s (95% BCI: 0.003, 0.066)], and IL-6 [0.041 m/s (95% BCI: 0.009, 0.073)] were observed, while variance interactions were observed between CR and exercise assignment [-0.458 m/s (95% BCI: -0.783, -0.138)], age [-0.557 m/s (95% BCI: -0.900, -0.221)], and gait speed [-0.530 m/s (95% BCI: -1.018, -0.062)] subgroups. Caloric restriction plus exercise yielded the greatest gait speed benefit among older adults with obesity. High BMI and IL-6 subgroups also improved gait speed in response to CR. Results provide a novel statistical framework for identifying treatment heterogeneity in RCTs.</p>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000049</institution-id>
                      <institution>National Institute on Aging</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>P60 AG10484</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Kritchevsky</surname>
                      <given-names>Stephen B.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award002">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000050</institution-id>
                      <institution>National Heart, Lung, and Blood Institute</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R01 HL076441</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Nicklas</surname>
                      <given-names>Barbara J.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award003">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000049</institution-id>
                      <institution>National Institute on Aging</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R01 AG020583</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Nicklas</surname>
                      <given-names>Barbara J.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award004">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000069</institution-id>
                      <institution>National Institute of Arthritis and Musculoskeletal and Skin Diseases</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R01 AR052528</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Messier</surname>
                      <given-names>Stephen P.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award005">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000050</institution-id>
                      <institution>National Heart, Lung, and Blood Institute</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R01 HL093713</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Nicklas</surname>
                      <given-names>Barbara J.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award006">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000049</institution-id>
                      <institution>National Institute on Aging</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R01 AG018915</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Kitzman</surname>
                      <given-names>Dalane W.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award007">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000049</institution-id>
                      <institution>National Institute on Aging</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>P30 AG21332</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Kritchevsky</surname>
                      <given-names>Stephen B.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award008">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000049</institution-id>
                      <institution>National Institute on Aging</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>T32 AG033534</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Kritchevsky</surname>
                      <given-names>Stephen B.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award009">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000049</institution-id>
                      <institution>National Institute on Aging</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R21 AG061344</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4286-9463</contrib-id>
                    <name>
                      <surname>Beavers</surname>
                      <given-names>Daniel P.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <funding-statement>This work was supported by the several grants from the National Institutes of Health: <ext-link xlink:href="https://reporter.nih.gov/" ext-link-type="uri">https://reporter.nih.gov/</ext-link> [reporter.nih.gov] (P60 AG10484 (SBK), R01 HL076441 (WJR), R01 AG020583 (BJN), R01 AR052528 (SPM), R01 HL093713 (BJN), R01 AG018915 (DWK), P30 AG21332 (SBK), T32 AG033534 (SBK), and R21 AG061344 (DPB)). The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="2"/>
                <table-count count="3"/>
                <page-count count="15"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>Data used in these analyses are 3rd party data available via request from the OAIC National Coordinating Center for the Claude D Pepper Older Americans Independence Centers <ext-link xlink:href="https://www.peppercenter.org/" ext-link-type="uri">https://www.peppercenter.org/</ext-link>. Authors were not given special access privileges to the datasets.</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>Data used in these analyses are 3rd party data available via request from the OAIC National Coordinating Center for the Claude D Pepper Older Americans Independence Centers <ext-link xlink:href="https://www.peppercenter.org/" ext-link-type="uri">https://www.peppercenter.org/</ext-link>. Authors were not given special access privileges to the datasets.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec001">
              <title>Introduction</title>
              <p>Clinical trials with continuous outcomes are conventionally designed to test aggregate mean differences, typically assuming homogeneous variances across treatment groups. While useful in guiding overall recommendations, this approach often fails to uncover prognostic indicators or underlying mechanisms of treatment effects. Indeed, experiential wisdom imparts that intervention efficacy can vary significantly by subgroup [<xref rid="pone.0267779.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0267779.ref002" ref-type="bibr">2</xref>], with individualized clinical decision making a fundamental tenet of precision medicine [<xref rid="pone.0267779.ref003" ref-type="bibr">3</xref>]. In pharmaceutical trials, for example, identification of “high responders” has led to prescribing practices aimed at maximizing treatment benefit while minimizing side effects [<xref rid="pone.0267779.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0267779.ref005" ref-type="bibr">5</xref>]. Consideration of individualized response in lifestyle-based trials has also helped to identify subgroups that are more likely to respond to exercise [<xref rid="pone.0267779.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0267779.ref007" ref-type="bibr">7</xref>] and nutrition [<xref rid="pone.0267779.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0267779.ref009" ref-type="bibr">9</xref>] prescriptions designed to mitigate chronic disease risk.</p>
              <p>While quantifying response variability is generally recognized as important [<xref rid="pone.0267779.ref010" ref-type="bibr">10</xref>], it can be technically challenging. For instance, variability often stems from within-subject characteristics [<xref rid="pone.0267779.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0267779.ref012" ref-type="bibr">12</xref>] which can be difficult to separate from random error [<xref rid="pone.0267779.ref013" ref-type="bibr">13</xref>]. Additionally, many trials are not designed with sufficient power to adequately examine mean subgroup differences; and attempts to do so rarely employ appropriate methodology to test for heterogeneity of variances. Assumed homogeneous variances can be problematic if they lead to biased variance estimates—negatively impacting analytic power, probabilities associated with individual response, and understanding of within-subgroup treatment effects. Furthermore, existing statistical methods are most appropriate for parallel group studies [<xref rid="pone.0267779.ref014" ref-type="bibr">14</xref>]; thus, the ability to test for treatment heterogeneity from alternate designs, such as studies with multiple interventions, are lacking.</p>
              <p>Consideration of heterogeneity of treatment response is an especially salient issue for weight loss trials conducted in older adults. While advanced age and excess adiposity are well-recognized risk factors for chronic disease and disability [<xref rid="pone.0267779.ref015" ref-type="bibr">15</xref>], variability surrounding the risk-benefit of intentional weight loss in this population—particularly as related to disability risk—has stalled widespread clinical recommendation [<xref rid="pone.0267779.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0267779.ref017" ref-type="bibr">17</xref>]. Encouragingly, evidence from the majority of lifestyle-based randomized controlled trials (RCTs) of caloric restriction and exercise in older adults demonstrate <italic toggle="yes">mean</italic> improvement in physical function following clinically meaningful (5–10%) weight loss [<xref rid="pone.0267779.ref015" ref-type="bibr">15</xref>]; however, substantial variation in the magnitude of change exists, with a subset of participants inevitably experiencing a null or negative effect [<xref rid="pone.0267779.ref018" ref-type="bibr">18</xref>]. Better understanding of the extent and predictors of inter-individual variability in physical function treatment response in this population has the potential to optimize geriatric obesity treatment strategies, while also providing a clinically relevant platform upon which to refine modeling approaches designed to manage heterogeneity.</p>
              <p>Several similarly designed RCTs testing the effects of caloric restriction and exercise on physical function among older adults with obesity were conducted over the past two decades at Wake Forest University and Wake Forest School of Medicine, providing an unique infrastructure to pool data to assess subgroup effects and account for inter-individual variability in treatment response [<xref rid="pone.0267779.ref019" ref-type="bibr">19</xref>–<xref rid="pone.0267779.ref026" ref-type="bibr">26</xref>]. Herein, we focus on change in gait speed, as it is arguably the most clinically relevant measure of physical function [<xref rid="pone.0267779.ref027" ref-type="bibr">27</xref>], and utilize a statistical modeling approach from a Bayesian framework to: 1) determine if there are inter-individual differences in gait speed as a result of randomization to caloric restriction, and 2) understand predictors of inter-individual variability in gait speed response, including demographic characteristics, health status, and exercise. We primarily hypothesize there will be an overall mean increase in gait speed because of caloric restriction, but that variability in gait speed change will also exist. We secondarily hypothesize that demographic characteristics, health status, and exercise assignment will interact with caloric restriction to influence gait speed mean and variance heterogeneity. Finally, as exploratory analyses we include continuous covariate data when available rather than dichotomized variables to determine if the subgroup differences persist using a linear model for the means and variances.</p>
            </sec>
            <sec sec-type="materials|methods" id="sec002">
              <title>Materials and methods</title>
              <sec id="sec003">
                <title>Studies and participant descriptions</title>
                <p>Relevant design characteristics of the included trials are summarized in <xref rid="pone.0267779.t001" ref-type="table">Table 1</xref>. Briefly, individual participant data from eight RCTs conducted at Wake Forest University or Wake Forest School of Medicine and housed within the Wake Forest Older Americans Independence Center data repository were eligible for inclusion in the pooled analysis. Study-specific inclusion and exclusion criteria are summarized in <xref rid="pone.0267779.s001" ref-type="supplementary-material">S1 Table</xref>. Individual study lengths varied, but all studies assessed fast-paced gait speed before and five/six months after assignment to either a caloric restriction intervention (CR) with or without exercise or to a non-caloric restriction control condition (NoCR) with or without exercise. The Wake Forest Health Sciences Institutional Review Board approved secondary analyses pertaining to the pooled project (IRB#54086). As all data/samples were fully anonymized, the requirement for informed consent was waived under Exemption Category 4. The final sample (n = 1343) includes all randomized participants with baseline and follow-up gait speed data.</p>
                <table-wrap position="float" id="pone.0267779.t001">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0267779.t001</object-id>
                  <label>Table 1</label>
                  <caption>
                    <title>Descriptive summary of randomized controlled trials included in the pooled analysis.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0267779.t001" id="pone.0267779.t001g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">Study Acronym and NCT#</th>
                          <th align="center" rowspan="1" colspan="1">N (%♂; %Black)</th>
                          <th align="center" rowspan="1" colspan="1">Mean Age (years)</th>
                          <th align="center" rowspan="1" colspan="1">Health Status</th>
                          <th align="center" rowspan="1" colspan="1">Intervention (n)</th>
                          <th align="center" rowspan="1" colspan="1">Complete Gait Speed (n)</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="2" colspan="1">
                            <bold>ADAPT</bold>
                          </td>
                          <td align="center" rowspan="2" colspan="1">231</td>
                          <td align="center" rowspan="4" colspan="1">68</td>
                          <td align="left" rowspan="2" colspan="1">Overweight/Obese</td>
                          <td align="right" rowspan="1" colspan="1">CR (n = 65)</td>
                          <td align="center" rowspan="4" colspan="1">218</td>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">AE (n = 57)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" colspan="1">
                            <bold>NCT00979043</bold>
                          </td>
                          <td align="center" rowspan="2" colspan="1">(29%; 21%)</td>
                          <td align="left" rowspan="2" colspan="1">OA</td>
                          <td align="right" rowspan="1" colspan="1">CR+AE (n = 54)</td>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">Control (n = 55)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>APPLE</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">33</td>
                          <td align="center" rowspan="2" colspan="1">70</td>
                          <td align="left" rowspan="2" colspan="1">Obese OA</td>
                          <td align="right" rowspan="1" colspan="1">CR (n = 15)</td>
                          <td align="center" rowspan="2" colspan="1">33</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>NCT02239939</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">(24%; 18%)</td>
                          <td align="right" rowspan="1" colspan="1">CR+VEST (n = 18)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" colspan="1">
                            <bold>CLIP</bold>
                          </td>
                          <td align="center" rowspan="2" colspan="1">267</td>
                          <td align="center" rowspan="3" colspan="1">67</td>
                          <td align="left" rowspan="2" colspan="1">Overweight/Obese</td>
                          <td align="right" rowspan="1" colspan="1">CR+AE (n = 95)</td>
                          <td align="center" rowspan="3" colspan="1">261</td>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">AE (n = 86)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>NCT00119795</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">(34%; 17%)</td>
                          <td align="left" rowspan="1" colspan="1">CVD/METS</td>
                          <td align="right" rowspan="1" colspan="1">Control (n = 86)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" colspan="1">
                            <bold>I’M FIT</bold>
                          </td>
                          <td align="center" rowspan="2" colspan="1">109</td>
                          <td align="center" rowspan="3" colspan="1">70</td>
                          <td align="left" rowspan="1" colspan="1">Overweight/Obese</td>
                          <td align="right" rowspan="2" colspan="1">CR+RE (n = 55)</td>
                          <td align="center" rowspan="3" colspan="1">109</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" colspan="1">At-risk for disability</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>NCT01049698</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">(45%; 12%)</td>
                          <td align="right" rowspan="1" colspan="1">RE (n = 54)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>IDEA</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">376</td>
                          <td align="center" rowspan="3" colspan="1">66</td>
                          <td align="left" rowspan="1" colspan="1">Overweight/Obese</td>
                          <td align="right" rowspan="1" colspan="1">CR (n = 120)</td>
                          <td align="center" rowspan="3" colspan="1">351</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" colspan="1">
                            <bold>NCT00381290</bold>
                          </td>
                          <td align="center" rowspan="2" colspan="1">(30%; 17%)</td>
                          <td align="left" rowspan="2" colspan="1">OA</td>
                          <td align="right" rowspan="1" colspan="1">AE (n = 124)</td>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">CR+AE (n = 132)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>INFINITE</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">146</td>
                          <td align="center" rowspan="3" colspan="1">69</td>
                          <td align="left" rowspan="3" colspan="1">Obese</td>
                          <td align="right" rowspan="1" colspan="1">Low CR+AE (n = 52)</td>
                          <td align="center" rowspan="3" colspan="1">142</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" colspan="1">
                            <bold>NCT01048736</bold>
                          </td>
                          <td align="center" rowspan="2" colspan="1">(25%; 24%)</td>
                          <td align="right" rowspan="1" colspan="1">High CR+AE (n = 51)</td>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">AE (n = 43)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>MEDIFAST</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">82</td>
                          <td align="center" rowspan="2" colspan="1">70</td>
                          <td align="left" rowspan="2" colspan="1">Obese/At-risk for disability</td>
                          <td align="right" rowspan="1" colspan="1">CR (n = 43)</td>
                          <td align="center" rowspan="2" colspan="1">80</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>NCT02730988</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">(27%; 25%)</td>
                          <td align="right" rowspan="1" colspan="1">Control (n = 39)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" colspan="1">
                            <bold>SECRET</bold>
                          </td>
                          <td align="center" rowspan="2" colspan="1">99</td>
                          <td align="center" rowspan="4" colspan="1">67</td>
                          <td align="left" rowspan="2" colspan="1">Overweight/Obese</td>
                          <td align="right" rowspan="1" colspan="1">CR (n = 24)</td>
                          <td align="center" rowspan="4" colspan="1">89</td>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">AE (n = 26)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" colspan="1">
                            <bold>NCT00959660</bold>
                          </td>
                          <td align="center" rowspan="2" colspan="1">(19%; 45%)</td>
                          <td align="left" rowspan="2" colspan="1">HFPEF</td>
                          <td align="right" rowspan="1" colspan="1">CR+AE (n = 25)</td>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">Control (n = 24)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t001fn001">
                      <p>NCT# = clinicaltrials.gov identifier; n = sample size; %♂ = percent male; m/s = meters per second; OA = osteoarthritis; CVD/METS = cardiovascular disease or metabolic syndrome; HFPEF = heart failure with preserved ejection fraction; CR = caloric restriction; AE = aerobic exercise; RE = resistance exercise; VEST = weighted vest use during activities of daily living; SPPB: Short physical performance battery.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="sec004">
                <title>Primary exposure measure: Caloric restriction</title>
                <p>Arms within each study were collapsed into CR (n = 749) and NoCR (n = 594) categories based on whether CR to induce weight loss was specified in the original study protocol. As shown in <xref rid="pone.0267779.t001" ref-type="table">Table 1</xref>, six studies randomized a subset of participants to traditional aerobic or resistance exercise (n = 854), with over half (n = 464) also receiving CR. Specifically, among thirteen study-specific interventions collapsed into the CR arm, five included participants randomized to CR only (n = 285), and six included participants randomized to CR combined with exercise (n = 464). Among ten study-specific arms collapsed into the NoCR arm, four included participants randomized to attention control (n = 204), and six included participants randomized to exercise only (n = 390).</p>
              </sec>
              <sec id="sec005">
                <title>Primary outcome measure: Change in objectively measured fast-paced gait speed</title>
                <p>Time recorded from the six-minute walk test (53% of the study sample) or fast-paced 400-meter walk test (47% of the study sample) was used to derive fast-paced gait speed at baseline and five/six month follow up. Gait speed, in general, is associated with survival among older adults [<xref rid="pone.0267779.ref028" ref-type="bibr">28</xref>], with long distance walk performance highly predictive of subsequent disability and death [<xref rid="pone.0267779.ref029" ref-type="bibr">29</xref>]. During the six-minute walk test [<xref rid="pone.0267779.ref030" ref-type="bibr">30</xref>], participants were asked to walk as far as they could around a circular track in six minutes. During the 400-meter walk test [<xref rid="pone.0267779.ref031" ref-type="bibr">31</xref>], participants were asked to briskly walk 10 laps of a 40-meter course and were given a maximum of 15 minutes to complete the test.</p>
              </sec>
              <sec id="sec006">
                <title>Covariate measures</title>
                <p>All studies captured self-reported demographic characteristics (age, sex, and race) and presence of select comorbidities [cardiovascular disease (CVD) and diabetes] via questionnaire at baseline. Standing height was measured using a clinical stadiometer and body mass was measured at baseline and five/six months follow up with a standard scale (with shoes and outer garments removed). Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared (kg/m<sup>2</sup>). Whole body fat mass was also measured in four studies (n = 958) using dual-energy x-ray absorptiometry (DXA) on the same machine [Hologic Discovery (Bedford, MA)] and following a standardized protocol [<xref rid="pone.0267779.ref019" ref-type="bibr">19</xref>, <xref rid="pone.0267779.ref022" ref-type="bibr">22</xref>–<xref rid="pone.0267779.ref024" ref-type="bibr">24</xref>]. Lastly, high-sensitivity C-reactive protein (CRP; n = 1293) and interleukin-6 (IL-6; n = 1288) were measured on all available blood samples using standard methodology [<xref rid="pone.0267779.ref032" ref-type="bibr">32</xref>].</p>
              </sec>
              <sec id="sec007">
                <title>Statistical analyses</title>
                <p>Baseline data were analyzed using descriptive statistics, with means and standard deviations computed for continuous variables and counts and proportions for discrete variables, overall and by CR assignment. Crude unadjusted comparisons of CR assignment on changes in weight and gait speed were compared using independent t-tests. For our primary analysis, we modeled the impact of CR assignment (<italic toggle="yes">x</italic><sub><italic toggle="yes">cr</italic></sub> = 0 for control and 1 for CR) on both the five/six-month gait speed change mean response (<italic toggle="yes">μ</italic><sub><italic toggle="yes">i</italic></sub>) and residual variability (<inline-formula id="pone.0267779.e001"><alternatives><graphic xlink:href="pone.0267779.e001.jpg" id="pone.0267779.e001g" position="anchor"/><mml:math id="M1" display="inline" overflow="scroll"><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>) for the <italic toggle="yes">i</italic>th individual by fitting a linear model assuming changes in gait speed are normally distributed, <inline-formula id="pone.0267779.e002"><alternatives><graphic xlink:href="pone.0267779.e002.jpg" id="pone.0267779.e002g" position="anchor"/><mml:math id="M2" display="inline" overflow="scroll"><mml:mi>N</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:math></alternatives></inline-formula>, where the mean:
<disp-formula id="pone.0267779.e003"><alternatives><graphic xlink:href="pone.0267779.e003.jpg" id="pone.0267779.e003g" position="anchor"/><mml:math id="M3" display="block" overflow="scroll"><mml:msub><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:math></alternatives><label>(1M)</label></disp-formula>
in which <italic toggle="yes">β</italic><sub>0,<italic toggle="yes">k</italic></sub> is a study-specific random intercept distributed <inline-formula id="pone.0267779.e004"><alternatives><graphic xlink:href="pone.0267779.e004.jpg" id="pone.0267779.e004g" position="anchor"/><mml:math id="M4" display="inline" overflow="scroll"><mml:mi>N</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:math></alternatives></inline-formula> where <italic toggle="yes">β</italic><sub>0</sub> is the control group mean and <inline-formula id="pone.0267779.e005"><alternatives><graphic xlink:href="pone.0267779.e005.jpg" id="pone.0267779.e005g" position="anchor"/><mml:math id="M5" display="inline" overflow="scroll"><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> is the study random effect, <italic toggle="yes">β</italic><sub>1</sub> is the mean CR treatment effect, and <italic toggle="yes">β</italic><sub><italic toggle="yes">bl</italic></sub> is the coefficient for baseline gait speed. Furthermore, we model the residual response variability <inline-formula id="pone.0267779.e006"><alternatives><graphic xlink:href="pone.0267779.e006.jpg" id="pone.0267779.e006g" position="anchor"/><mml:math id="M6" display="inline" overflow="scroll"><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> using:
<disp-formula id="pone.0267779.e007"><alternatives><graphic xlink:href="pone.0267779.e007.jpg" id="pone.0267779.e007g" position="anchor"/><mml:math id="M7" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">log</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>ϕ</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>ϕ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:math></alternatives><label>(1V)</label></disp-formula>
such that differences in group response variability can be tested by comparing the parameter <italic toggle="yes">ϕ</italic><sub>1</sub> to 0, i.e., identifying whether the 95% posterior credible interval contains 0, and the CR groups’ variances are <inline-formula id="pone.0267779.e008"><alternatives><graphic xlink:href="pone.0267779.e008.jpg" id="pone.0267779.e008g" position="anchor"/><mml:math id="M8" display="inline" overflow="scroll"><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">exp</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>ϕ</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0267779.e009"><alternatives><graphic xlink:href="pone.0267779.e009.jpg" id="pone.0267779.e009g" position="anchor"/><mml:math id="M9" display="inline" overflow="scroll"><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">exp</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>ϕ</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>ϕ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>. Using the log-scale for modeling variance terms adds convenience because to the support for log(<italic toggle="yes">σ</italic><sup>2</sup>) spans the full real line; therefore, all model parameters (<bold><italic toggle="yes">β</italic></bold>, <bold><italic toggle="yes">ϕ</italic></bold>) can be fit using diffuse normal prior distributions (<italic toggle="yes">N</italic>(0,10)), and <inline-formula id="pone.0267779.e010"><alternatives><graphic xlink:href="pone.0267779.e010.jpg" id="pone.0267779.e010g" position="anchor"/><mml:math id="M10" display="inline" overflow="scroll"><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> with inverse-gamma(0.001,0.001), to minimize prior assumptions and to allow the data likelihood to dominate the posterior estimates.</p>
                <p>Our secondary objective is to estimate and compare the impact of CR assignment and covariates, whether a continuous covariate <italic toggle="yes">x</italic><sub><italic toggle="yes">s</italic></sub> or discrete subgroup membership (<italic toggle="yes">x</italic><sub><italic toggle="yes">s</italic></sub> = 0 vs. 1), on changes in gait speed. We added terms for covariates and the treatment-covariate interaction such that:
<disp-formula id="pone.0267779.e011"><alternatives><graphic xlink:href="pone.0267779.e011.jpg" id="pone.0267779.e011g" position="anchor"/><mml:math id="M11" display="block" overflow="scroll"><mml:msub><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:math></alternatives><label>(2M)</label></disp-formula>
where <italic toggle="yes">β</italic><sub>2</sub> is the coefficient for key covariates/subgroup membership, <italic toggle="yes">β</italic><sub>3</sub> quantifies the interaction, and all remaining model parameters remain the same as (1M). Furthermore, for the response variance we modified (1V) to include subgroup/covariate term <italic toggle="yes">ϕ</italic><sub>2</sub> and interaction term <italic toggle="yes">ϕ</italic><sub>3</sub> as follows:
<disp-formula id="pone.0267779.e012"><alternatives><graphic xlink:href="pone.0267779.e012.jpg" id="pone.0267779.e012g" position="anchor"/><mml:math id="M12" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">log</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>ϕ</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>ϕ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>ϕ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>ϕ</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>.</mml:mo></mml:math></alternatives><label>(2V)</label></disp-formula></p>
                <p>The combinations of Model (2M) and (2V) permitted separate estimates for treatment means and variances across continuous or discrete subgroups and tests for differences in treatment response variability across covariate levels by comparing <italic toggle="yes">ϕ</italic><sub>3</sub> to 0. Again, we fit noninformative diffuse prior distributions as described above using OpenBUGS.</p>
                <p>Subgroups were defined by dichotomizing continuous baseline predictors: age ≥65 years, median BMI &gt;33.3 kg/m<sup>2</sup>, sex-specific median percent body fat (male median: 32.1%, female median: 44.5%), IL-6 &gt;2.5 pg/dL [<xref rid="pone.0267779.ref033" ref-type="bibr">33</xref>], CRP &gt;3.0 mg/L [<xref rid="pone.0267779.ref034" ref-type="bibr">34</xref>] and gait speed &lt;1.0 m/s [<xref rid="pone.0267779.ref035" ref-type="bibr">35</xref>]. Dichotomous baseline variables [sex (male/female), race (black/white), comorbidity status (CVD and diabetes: yes/no), and randomized assignment to exercise (yes/no)] were also analyzed as subgroups. Continuous covariates (age, BMI, percent body fat, log IL-6, log CRP, and baseline gait speed) were included in separate exploratory models as linear predictors for means and variances, with log adjustment for right skewed biomarkers. Mean models of gait speed response adjusted for study and baseline gait speed, except models in which baseline gait speed and gait speed subgroup were predictors, means were adjusted only for study. All associations and comparisons were determined based on whether the 95% Bayesian Credible Interval (BCI; analogous to a frequentist 95% Confidence Interval), overlaps the null value of 0, and all variability estimates are presented as standard deviations for ease of interpretation. Results focus on the effect of CR and whether CR interacts with subgroups or covariates. Summary data and frequentist comparisons were performed using SAS software, version 9.4 (SAS Institute, Cary, NC) using 2-sided hypothesis tests and assuming a Type 1 error rate of 0.05, while Bayesian models were created using OpenBUGS and executed in R using the package R2OpenBUGS.</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec008">
              <title>Results and discussion</title>
              <sec id="sec009">
                <title>Baseline characteristics of study sample</title>
                <p>Analyses were performed on a sample of 1343 participants, with baseline demographic and health characteristics presented in <xref rid="pone.0267779.t002" ref-type="table">Table 2</xref>. Participants were older [mean (SD), 67.7 (5.4) years], predominantly female (69.8%), white (79.2%), and living with obesity [BMI: 33.9 (4.4) kg/m<sup>2</sup>]. Overall prevalence of self-reported CVD (4.9%) and diabetes (14.4%) was low and did not differ by CR assignment; however, most participants had higher levels of inflammation defined as IL-6 ≥2.5 pg/mL (55.0%) and CRP ≥3.0 mg/L (60.1%). Fast-paced gait speed was 1.2 (0.2) m/s, indicative of a well-functioning cohort at baseline [<xref rid="pone.0267779.ref036" ref-type="bibr">36</xref>], with only 174 (13.0%) presenting with gait speed below 1.0 m/s. Participant characteristics were mostly similar across treatment groups with respect to all baseline characteristics, except for a small difference in baseline body fat percentage [CR: 41.1 (7.0) % vs. NoCR: 40.2 (7.2) %, <italic toggle="yes">p</italic> = 0.04] among the subset of participants with baseline DXA (n = 958). Finally, most (63.6%) participants were assigned to some form of exercise, although proportions were comparable across groups (CR: 61.9% vs. NoCR: 65.7%, <italic toggle="yes">p</italic> = 0.16).</p>
                <table-wrap position="float" id="pone.0267779.t002">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0267779.t002</object-id>
                  <label>Table 2</label>
                  <caption>
                    <title>Baseline characteristics of study sample, overall and by treatment group.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0267779.t002" id="pone.0267779.t002g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">Variable</th>
                          <th align="right" rowspan="1" colspan="1">N<xref rid="t002fn002" ref-type="table-fn"><sup>a</sup></xref></th>
                          <th align="center" rowspan="1" colspan="1">Overall (N = 1343)</th>
                          <th align="right" rowspan="1" colspan="1">N<xref rid="t002fn002" ref-type="table-fn"><sup>a</sup></xref></th>
                          <th align="center" rowspan="1" colspan="1">CR (N = 749)</th>
                          <th align="right" rowspan="1" colspan="1">N<xref rid="t002fn002" ref-type="table-fn"><sup>a</sup></xref></th>
                          <th align="center" rowspan="1" colspan="1">NoCR (N = 594)</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Age in years</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">67.7 (5.4)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">67.6 (5.4)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">67.7 (5.3)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    ≥65 years</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">932 (69.4)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">527 (70.4)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">405 (68.2)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Female Sex, n (%)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">938 (69.8)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">533 (71.2)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">405 (68.2)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Black Race, n (%)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">1328</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">276 (20.8)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">742</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">161 (21.7)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">115 (19.6)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Presence of Comorbidities, n (%)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    Cardiovascular Disease</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">1213</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">60 (4.9)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">662</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">33 (5.0)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">551</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">27 (4.9)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    Diabetes</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">1329</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">191 (14.4)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">739</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">100 (13.5)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">590</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">91 (15.4)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Body Weight/Composition</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    Weight in kg</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">93.7 (15.3)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">93.8 (15.2)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">93.7 (15.6)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    BMI in kg/m<sup>2</sup></td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">33.9 (4.4)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">34.0 (4.3)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">33.7 (4.6)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">        ≥ median BMI<xref rid="t002fn004" ref-type="table-fn"><sup>c</sup></xref></td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">670 (49.9)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">383 (51.1)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">287 (48.3)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    Percent body fat</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">958</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">40.7 (7.1)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">537</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">41.1 (7.0)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">421</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">40.2 (7.2)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">        ≥sex-specific median<xref rid="t002fn005" ref-type="table-fn"><sup>d</sup></xref></td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">958</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">480 (50.1)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">537</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">281 (52.3)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">421</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">199 (47.3)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Inflammatory Burden</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    IL-6 in pg/dL</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">1288</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">3.7 (7.2)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">720</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">4.0 (9.3)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">568</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">3.4 (2.8)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">        ≥2.5 pg/dL</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">1288</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">708 (55.0)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">720</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">410 (56.9)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">568</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">298 (52.5)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    CRP in mg/L</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">1293</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">7.1 (9.3)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">726</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">7.4 (9.3)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">567</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">6.7 (9.2)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">        ≥3.0 mg/L</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">1293</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">777 (60.1)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">726</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">438 (60.3)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1">567</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">339 (59.8)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Fast Paced Gait Speed (m/s)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">1.2 (0.2)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">1.2 (0.2)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">1.2 (0.2)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">        &lt;1.0 m/s</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">174 (13.0)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">91 (12.1)</td>
                          <td align="right" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">83 (14.0)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t002fn001">
                      <p>Abbreviations: BMI: Body Mass Index; IL-6: Interleukine-6; CRP: C-reactive Protein</p>
                    </fn>
                    <fn id="t002fn002">
                      <p><sup><bold>a</bold></sup>Sample sizes provided only when they differ from column headers.</p>
                    </fn>
                    <fn id="t002fn003">
                      <p><sup>b</sup>Data are presented as mean (SD) or n (%).</p>
                    </fn>
                    <fn id="t002fn004">
                      <p><sup>c</sup>Median BMI was 33.3kg/m<sup>2</sup>.</p>
                    </fn>
                    <fn id="t002fn005">
                      <p><sup>d</sup>Median DXA-acquired percent fat mass was 32.1% for males and 44.5% for females.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="sec010">
                <title>Overall effects on of CR assignment on weight loss and gait speed response</title>
                <p>On average, participants assigned to CR significantly reduced their body mass more than those assigned to NoCR [absolute changes CR: -7.7 (5.8) kg vs. NoCR: -0.9 (3.5) kg, <italic toggle="yes">p</italic>&lt;0.01; relative changes: CR: -8.1 (5.9) % vs. NoCR: -1.0 (3.7) %; <italic toggle="yes">p</italic>&lt;0.01], with significant differences BMI change as well [CR: -2.8 (2.1) kg/m<sup>2</sup> vs. NoCR -0.4 (1.3) kg/m<sup>2</sup>; <italic toggle="yes">p</italic>&lt;0.01]. In unadjusted analyses, CR participants showed a significant increase in gait speed compared to NoCR [+0.10 (0.16) m/s vs. +0.07 (0.15) m/s, respectively, <italic toggle="yes">p</italic>&lt;0.01] (see <xref rid="pone.0267779.g001" ref-type="fig">Fig 1</xref>). After adjustment for baseline gait speed and study, CR continued to yield a mean increase in gait speed [+0.021 m/s (95% Bayesian Credible Interval, BCI: 0.005, 0.037)], which was slightly attenuated compared to the unadjusted comparison. However, as illustrated in <xref rid="pone.0267779.g001" ref-type="fig">Fig 1</xref>, there were no differences in standard deviations between groups [CR: +0.143 m/s (95% BCI: 0.136, 0.151) vs. NoCR: +0.141 m/s (95% BCI: 0.133, 0.150)], indicating that although means differed by CR treatment, there was no observable heterogeneity of response variances due to overall CR assignment.</p>
                <fig position="float" id="pone.0267779.g001">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0267779.g001</object-id>
                  <label>Fig 1</label>
                  <caption>
                    <p>Crude six-month mean (95% Bayesian Credible Interval) change in percent weight (A) and fast-paced gait speed (B) by caloric restriction assignment group.</p>
                  </caption>
                  <graphic xlink:href="pone.0267779.g001" position="float"/>
                </fig>
              </sec>
              <sec id="sec011">
                <title>Heterogeneity of gait speed change means and standard deviations across subgroups</title>
                <p>Model adjusted outcomes that estimate treatment and subgroup heterogeneity across baseline demographic and health characteristic subgroups are presented in <xref rid="pone.0267779.t003" ref-type="table">Table 3</xref>. Means are estimated from Model (2M) and standard deviations are estimated from Model (2V). Significant mean interactions between CR assignment and subgroup membership were observed for BMI (≥33.3 kg/m<sup>2</sup>) and IL-6 (≥2.5 mg/dL), while significant variance interactions were observed for age (≥65 years) and low gait speed (&lt;1.0 m/s). Subgroups based on baseline BMI produced enhanced gait speed effects for CR among the higher BMI subgroup compared to the lower subgroup [CR benefit for BMI ≥ median: +0.039 m/s (95% BCI: 0.016, 0.061) vs. CR benefit for BMI &lt; median: +0.004 m/s (95% BCI: -0.018, 0.027)], and participants with higher baseline IL-6 similarly experienced enhanced gait speed benefit from CR compared to the lower IL-6 subgroup [CR benefit for IL-6 ≥2.5 pg/mL: +0.041 m/s (95% BCI: 0.019, 0.62) vs. CR benefit for IL-6 &lt;2.5 pg/mL: -0.001 m/s (95% BCI: -0.025, 0.024)]. Similarly, the subgroups of age and gait speed are associated with differences in standard deviations, with CR inducing increased variability among younger (&lt;65 years) participants [CR vs. NoCR: +0.029 m/s (95% BCI: 0.009, 0.050)] vs. older (≥65 years) participants [CR vs. NoCR: -0.010 m/s (95% BCI: -0.024, 0.003)]; and reduced variability among lower baseline gait speed (&lt;1.0 m/s) participants [CR vs. NoCR: -0.034 m/s (95% BCI: -0.075, 0.004)] compared to higher gait speed (≥1.0 m/s) participants [CR vs. NoCR: 0.010 m/s (95% BCI: -0.002, 0.022)]. Similar effects for the means were observed when modeling BMI and log IL-6 as continuous variables, where the added benefit of CR persisted with higher BMI and log IL-6 values; furthermore, the baseline gait speed interaction with CR persisted for the standard deviations using continuous baseline gait speed but not for continuous age (<xref rid="pone.0267779.s002" ref-type="supplementary-material">S2 Table</xref>).</p>
                <table-wrap position="float" id="pone.0267779.t003">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0267779.t003</object-id>
                  <label>Table 3</label>
                  <caption>
                    <title>Subgroup mean and standard deviation estimates in gait speed change, presented by treatment group and after fitting an interaction term.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0267779.t003" id="pone.0267779.t003g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="center" rowspan="1" colspan="1"/>
                          <th align="center" colspan="4" rowspan="1">Δ Gait Speed Mean Estimates (95% Bayesian Credible Interval)<xref rid="t003fn004" ref-type="table-fn"><sup>c</sup></xref></th>
                          <th align="center" colspan="4" rowspan="1">Δ Gait Speed Standard Deviation Estimates (95% Bayesian Credible Interval)<xref rid="t003fn005" ref-type="table-fn"><sup>d</sup></xref></th>
                        </tr>
                        <tr>
                          <th align="center" rowspan="1" colspan="1"/>
                          <th align="center" rowspan="1" colspan="1">NoCR</th>
                          <th align="center" rowspan="1" colspan="1">CR</th>
                          <th align="center" rowspan="1" colspan="1">CR–NoCR</th>
                          <th align="center" rowspan="1" colspan="1">Interaction</th>
                          <th align="center" rowspan="1" colspan="1">NoCR</th>
                          <th align="center" rowspan="1" colspan="1">CR</th>
                          <th align="center" rowspan="1" colspan="1">CR–NoCR</th>
                          <th align="center" rowspan="1" colspan="1">Interaction<xref rid="t003fn005" ref-type="table-fn"><sup>b</sup></xref></th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" colspan="9" style="background-color:#FFFFFF" rowspan="1">Age</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    &lt;65 years</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.067 (-0.002, 0.136)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.081 (0.010, 0.149)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.014 (-0.016, 0.043)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.011 (-0.024, 0.046)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.128 (0.115, 0.143)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.158 (0.143, 0.174)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.029 (0.009, 0.050)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-0.557 (-0.900, -0.221)*</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    ≥65 years</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.041 (-0.027, 0.107)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.065 (-0.002, 0.131)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.024 (0.005, 0.044)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.147 (0.137, 0.159)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.137 (0.129, 0.146)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-0.010 (-0.024, 0.003)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" colspan="9" style="background-color:#FFFFFF" rowspan="1">Sex</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    Male</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.086 (0.014, 0.155)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.090 (0.020, 0.159)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.004 (-0.028, 0.037)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.026 (-0.011, 0.063)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.156 (0.141, 0.173)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.159 (0.145, 0.175)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.003 (-0.018, 0.025)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.021 (-0.314, 0.352)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    Female</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.031 (-0.038, 0.097)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.061 (-0.008, 0.127)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.030 (0.012, 0.048)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.131 (0.123, 0.141)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.136 (0.128, 0.144)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.004 (-0.008, 0.017)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" colspan="9" style="background-color:#FFFFFF" rowspan="1">Race</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    White</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.056 (-0.014, 0.124)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.071 (0.001, 0.138)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.015 (-0.004, 0.033)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.032 (-0.005, 0.069)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.143 (0.134, 0.153)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.147 (0.138, 0.156)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.004 (-0.010, 0.016)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-0.025 (-0.422, 0.364)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    Black</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.011 (-0.062, 0.081)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.058 (-0.013, 0.128)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.047 (0.015, 0.079)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.129 (0.113, 0.148)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.130 (0.116, 0.146)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.002 (-0.022, 0.024)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" colspan="9" style="background-color:#FFFFFF" rowspan="1">Cardiovascular Disease</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    No</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.049 (-0.021, 0.118)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.069 (-0.000, 0.138)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.020 (0.004, 0.037)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.018 (-0.054, 0.090)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.142 (0.134, 0.151)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.144 (0.136, 0.152)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.002 (-0.009, 0.014)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-0.424 (-1.258, 0.356)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    Yes</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.016 (-0.074, 0.104)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.055 (-0.026, 0.135)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.039 (-0.032, 0.109)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.143 (0.109, 0.194)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.117 (0.091, 0.151)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-0.026 (-0.084, 0.024)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" colspan="9" style="background-color:#FFFFFF" rowspan="1">Diabetes</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    No</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.052 (-0.017, 0.120)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.068 (-0.001, 0.134)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.016 (-0.002, 0.033)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.036 (-0.014, 0.084)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.140 (0.131, 0.149)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.140 (0.132, 0.148)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.000 (-0.012, 0.012)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.190 (-0.259, 0.655)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    Yes</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.021 (-0.054, 0.093)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.072 (-0.003, 0.146)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.051 (0.005, 0.097)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.148 (0.128, 0.173)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.164 (0.142, 0.190)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.015 (-0.017, 0.049)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" colspan="9" style="background-color:#FFFFFF" rowspan="1">Body Mass Index (using median split: 33.3 kg/<sup>2</sup>)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    &lt;median BMI</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.067 (-0.002, 0.135)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.071 (0.002, 0.138)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.004 (-0.018, 0.027)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.034 (0.003, 0.066)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.144 (0.133, 0.156)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.146 (0.135, 0.157)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.002 (-0.014, 0.018)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.037 (-0.271, 0.343)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    ≥median BMI</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.028 (-0.040, 0.096)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.067 (-0.000, 0.134)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.039 (0.016, 0.061)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.137 (0.126, 0.149)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.141 (0.131, 0.152)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.004 (-0.011, 0.020)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" colspan="9" style="background-color:#FFFFFF" rowspan="1">Percent Fat Mass (using sex-specific median split: male = 32.1%, female = 44.5%</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    &lt;Sex-specific median</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.073 (-0.020, 0.165)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.097 (0.004, 0.187)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.024 (-0.003, 0.051)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-0.001 (-0.039, 0.036)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.143 (0.130, 0.159)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.142 (0.130, 0.155)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-0.002 (-0.021, 0.017)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-0.120 (-0.493, 0.263)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    ≥Sex-specific median</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.054 (-0.039, 0.145)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.077 (-0.016, 0.167)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.023 (-0.003, 0.050)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.143 (0.130, 0.159)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.133 (0.123, 0.146)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-0.010 (-0.028, 0.009)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" colspan="9" style="background-color:#FFFFFF" rowspan="1">Interleukin-6</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    &lt;2.5 pg/mL</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.068 (-0.005, 0.140)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.068 (-0.006, 0.139)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-0.001 (-0.025, 0.024)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.041 (0.009, 0.073)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.142 (0.130, 0.154)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.153 (0.142, 0.166)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.012 (-0.005, 0.029)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-0.212 (-0.527, 0.109)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    ≥2.5 pg/mL</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.029 (-0.043, 0.100)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.069 (-0.003, 0.140)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.041 (0.019, 0.062)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.137 (0.127, 0.149)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.134 (0.125, 0.144)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-0.004 (-0.019, 0.011)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" colspan="9" style="background-color:#FFFFFF" rowspan="1">C-Reactive Protein</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    &lt;3.0 mg/L</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.035 (-0.036, 0.105)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.064 (-0.006, 0.134)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.029 (0.009, 0.049)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-0.018 (-0.052, 0.015)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.137 (0.127, 0.148)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.132 (0.124, 0.142)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-0.005 (-0.019, 0.009)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.246 (-0.084, 0.572)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    ≥3.0 mg/L</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.065 (-0.007, 0.135)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.076 (0.005, 0.147)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.011 (-0.016, 0.038)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.144 (0.131, 0.159)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.157 (0.145, 0.172)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.013 (-0.006, 0.033)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" colspan="9" style="background-color:#FFFFFF" rowspan="1">Baseline Fast Paced Gait Speed<xref rid="t003fn002" ref-type="table-fn"><sup>a</sup></xref></td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    ≥1.0 m/s</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.041 (-0.023, 0.104)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.062 (-0.002, 0.124)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.021 (0.004, 0.038)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.014 (-0.044, 0.071)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.137 (0.128, 0.146)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.146 (0.139, 0.155)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.010 (-0.002, 0.022)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-0.530 (-1.018, -0.062)*</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">    &lt;1.0 m/s</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.101 (0.025, 0.175)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.136 (0.064, 0.205)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.035 (-0.019, 0.090)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.189 (0.161, 0.223)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.155 (0.134, 0.181)*</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-0.034 (-0.075, 0.004)</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t003fn001">
                      <p>Abbreviations: NoCR: Non-caloric restriction arms; CR: Caloric restriction arms; kg: kilogram; m: meter; pg: picogram; mL: milliliter; mg: milligram: L: liter; s: second. *Denotes statistically significant (<italic toggle="yes">p</italic>&lt;0.05).</p>
                    </fn>
                    <fn id="t003fn002">
                      <p><sup>a</sup>Baseline gait speed subgroup model was not additionally adjusted for baseline gait speed.</p>
                    </fn>
                    <fn id="t003fn003">
                      <p><sup>b</sup>Interaction term presented in log-adjusted scale.</p>
                    </fn>
                    <fn id="t003fn004">
                      <p><sup>c</sup>Means (95% BCI) estimated from Model (2M) of statistical analysis section. NoCR estimates correspond to <italic toggle="yes">β</italic><sub>0</sub> (row 1) and <italic toggle="yes">β</italic><sub>0</sub>+<italic toggle="yes">β</italic><sub>2</sub> (row 2), CR estimates correspond to <italic toggle="yes">β</italic><sub>0</sub>+<italic toggle="yes">β</italic><sub>1</sub> (row 1) and <italic toggle="yes">β</italic><sub>0</sub>+<italic toggle="yes">β</italic><sub>1</sub>+<italic toggle="yes">β</italic><sub>3</sub> (row 2), CR—NoCR correspond to <italic toggle="yes">β</italic><sub>1</sub> (row 1) and <italic toggle="yes">β</italic><sub>1</sub>+<italic toggle="yes">β</italic><sub>3</sub>+<italic toggle="yes">β</italic><sub>2</sub> (row 2). Interaction estimates correspond to <italic toggle="yes">β</italic><sub>3</sub>.</p>
                    </fn>
                    <fn id="t003fn005">
                      <p><sup>d</sup>Standard deviations (95% BCI) estimated from Model (2V) of statistical analysis section. NoCR estimates correspond to exp(<italic toggle="yes">ϕ</italic><sub>0</sub>) (row 1) and exp(<italic toggle="yes">ϕ</italic><sub>0</sub>+<italic toggle="yes">ϕ</italic><sub>2</sub>) (row 2), CR estimates correspond to exp(<italic toggle="yes">ϕ</italic><sub>0</sub>+<italic toggle="yes">ϕ</italic><sub>1</sub>) (row 1) and exp(<italic toggle="yes">ϕ</italic><sub>0</sub>+<italic toggle="yes">ϕ</italic><sub>1</sub>+<italic toggle="yes">ϕ</italic><sub>3</sub>) (row 2), CR—NoCR correspond to exp(<italic toggle="yes">ϕ</italic><sub>1</sub>) (row 1) and exp(<italic toggle="yes">ϕ</italic><sub>1</sub>+<italic toggle="yes">ϕ</italic><sub>3</sub>−<italic toggle="yes">ϕ</italic><sub>2</sub>) (row 2). Interaction estimates correspond to <italic toggle="yes">ϕ</italic><sub>3</sub> (log-adjusted scale).</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>A significant interaction for mean gait speed change was observed between random assignment to exercise and CR [+0.037 m/s (95% BCI: 0.004, 0.070)]. As illustrated in <xref rid="pone.0267779.g002" ref-type="fig">Fig 2</xref>, participants who were not assigned to exercise had no difference in gait speed change according to CR assignment [-0.000 m/s (95% BCI: -0.026, 0.026)], but participants assigned to exercise plus CR had an added gait speed benefit compared to exercise plus NoCR [+0.037 m/s (95% BCI: 0.016, 0.057)]. Furthermore, exercise and CR significantly interact with regard to the standard deviations [-0.458 m/s (95% BCI: -0.783, -0.138)], leading to an increased SD attributable to CR among participants not assigned to exercise [+0.018 m/s (95% BCI: 0.002, 0.034)] but a non-significant reduction in the standard deviation among CR participants assigned to exercise [-0.012 m/s (95% BCI: -0.026, 0.003)].</p>
                <fig position="float" id="pone.0267779.g002">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0267779.g002</object-id>
                  <label>Fig 2</label>
                  <caption>
                    <p>Effect of exercise subgroup membership on change in fast-paced gait speed mean (A) and variance (B) heterogeneity in response to caloric restriction. Presented as model-adjusted parameter means and 95% Bayesian Credible Intervals.</p>
                  </caption>
                  <graphic xlink:href="pone.0267779.g002" position="float"/>
                </fig>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec012">
              <title>Discussion</title>
              <p>The purpose of this study was to develop an approach to quantify the magnitude and predictors of variability in treatment response, specifically focusing on the clinical conundrum of physical function response to CR among older adults with obesity. Overall, we found that mean gait speed modestly and uniformly increased with CR (+0.02 m/s, compared to NoCR), which was largely driven by the CR-exercise interaction. The combination of CR and exercise had a significantly stronger and more consistent effect on mean gait speed change (+0.04 m/s) than exercise alone, and exercise had an interaction effect on CR treatment response variability. Additionally, those with a high BMI and elevated IL-6 experienced enhanced gait speed improvement in response to CR, while CR-subgroup interactions in gait speed variance were observed in age and low gait speed subgroups. Results of this study provide a statistical framework for examining inter-individual variability in treatment response and highlight a situation where identification of specific phenotypic characteristics (i.e., within this specific scientific domain: high BMI, and high IL-6) may help guide clinical decision making.</p>
              <p>Consideration of inter-individual variability in treatment response, while often ignored in clinical trials, can offer insight into maximizing treatment efficacy. Indeed, previous clinical studies examining response variability have reported considerable treatment effect heterogeneity across various fields, such as exercise [<xref rid="pone.0267779.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0267779.ref007" ref-type="bibr">7</xref>] pharmaceuticals [<xref rid="pone.0267779.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0267779.ref005" ref-type="bibr">5</xref>] and dietary supplements [<xref rid="pone.0267779.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0267779.ref009" ref-type="bibr">9</xref>]. Within the field of geriatric weight management, our results suggest that older adults presenting with elevated BMI or inflammatory burden are more likely see CR-associated improvement in physical function in comparison to lower BMI/inflammatory burden counterparts. This finding is likely explained by the inflammatory nature of adipose tissue [<xref rid="pone.0267779.ref037" ref-type="bibr">37</xref>] and its association with impaired muscle fiber contractility [<xref rid="pone.0267779.ref038" ref-type="bibr">38</xref>]. Indeed, mobility impairment in older adults is associated with high BMI [<xref rid="pone.0267779.ref039" ref-type="bibr">39</xref>] and/or IL-6 [<xref rid="pone.0267779.ref033" ref-type="bibr">33</xref>] both of which can be reduced with CR [<xref rid="pone.0267779.ref040" ref-type="bibr">40</xref>]. Our observation that exercise paired with CR results in greater improvement in gait speed response as compared to CR alone, while notable, is not necessarily surprising. As structured exercise yields well-recognized improvement in muscle coordination and strength—even among older, sedentary adults [<xref rid="pone.0267779.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0267779.ref042" ref-type="bibr">42</xref>]—the combination of CR with exercise would be expected to further improve gait speed. What is surprising, however, is that CR plus exercise yields markedly and uniformly greater improvement in gait speed change (i.e. +0.04 m/s) versus <italic toggle="yes">exercise alone</italic>, and that CR alone had the same effect as the control condition (NoCR, no exercise) on gait speed change. These findings emphasize the need to combine therapies in order to maximize functional benefit and also temper the concern that CR alone (and presumably associated muscle loss [<xref rid="pone.0267779.ref043" ref-type="bibr">43</xref>]) exacerbates functional decline in older adults.</p>
              <p>Findings surrounding variance interactions for exercise, age, and baseline gait speed indicate that CR can have significantly different effects on gait speed variability, which in the case of age and baseline speed may occur in the absence of a significant subgroup by treatment mean interaction. This observation is important to note, as exploration of subgroup effects for heterogeneous response in the absence of differential treatment effects on standard deviations has been criticized [<xref rid="pone.0267779.ref014" ref-type="bibr">14</xref>]; yet, our findings suggest there may be meaningful knowledge to be gained. For example, a situation could exist where differential achievement of clinically meaningful gait speed change (i.e. ≥0.05 m/s [<xref rid="pone.0267779.ref044" ref-type="bibr">44</xref>]) could occur within subgroups in the absence of a significant treatment difference in variances if the intervention induces different variability within subgroups. Furthermore, failure to quantify inter-individual variability in clinical trials may result in subgroups that experience a beneficial or negative treatment effect that differs from the overall study effect.</p>
              <p>Future trials that use observed variability estimates without taking subgroups into account can yield biased and inaccurate power estimates. For an example from these analyses, a hypothetical trial of CR among women could use estimates from <xref rid="pone.0267779.t003" ref-type="table">Table 3</xref> to identify that the standard deviation of gait speed change among women is roughly comparable by randomization group (0.133 m/s), but this estimate is lower than the overall (men and women) standard deviation of change (0.142 m/s). A future trial using this information would require 110 observations per group rather than 128 per group for a 0.05 m/s difference using a two-sample t-test with 80% power, which could help improve study efficiency and decrease the budget. Collectively, these observations underscore the importance of testing for differences in variances (across treatment arms and within subgroups) when possible, to enhance the utility of clinical trial findings.</p>
              <p>Strengths of this study include the uniquely large sample achieved by pooling individual level data from RCTs with similar major design elements and standardized protocols collecting gait speed data (including training/certification of functional assessors and use of standardized script language). In addition, heterogeneity among design aspects of the trials can be acknowledged as a limitation, particularly among differing CR targets and entry criteria, but it also broadens the generalizability of our findings and protects against over-interpretation of idiosyncratic results from any single study. Our subgroup analysis featured dichotomized and continuous predictors, with categorization based on medians to maximize power (BMI, body fat percentage) or empirical evidence (IL-6, CRP, gait speed). Although dichotomization of continuous variables is commonly criticized in the biostatistical literature [<xref rid="pone.0267779.ref045" ref-type="bibr">45</xref>], it is reassuring that we observed similar results using continuous linear predictors for both means and variances, with the sole exception of age. The use of studies performed at a single site could potentially limit the generalizability of the results due to circumstances and participants unique to the Winston-Salem area. Additionally, some individuals were participants in multiple trials; this could affect the assumption of independence between a small proportion of observations. Finally, while exercise assignment was shown to have heterogeneous effects with CR, unfortunately this analysis does not allow for consideration of exercise prescription characteristics, including frequency, intensity, type, and duration. We encourage future research efforts to confirm and extend this finding.</p>
            </sec>
            <sec sec-type="conclusions" id="sec013">
              <title>Conclusions</title>
              <p>In conclusion, this study examined gait speed response from CR and exercise trials among older adults and found uniformly increased gait speed with CR compared to NoCR, which was largely driven by exercise. Results also suggest that exercise combined with CR yields additional gait speed benefit for older adults compared with exercise alone, and that older adults with high baseline BMI and IL-6 are likely to experience enhanced gait speed change with CR. Furthermore, exercise treatment assignment as well as membership in age or baseline gait speed subgroups can yield differences in gait speed change variances. Our modeling approach provides a framework to detect novel sources of mean and variance response heterogeneity due to treatment interactions with covariates, while also creating an avenue for exploring heterogeneity in factorial design studies. We implore future clinical trials to consider mean and variance treatment response heterogeneity as a part of a pre-specified analytic strategy, when possible.</p>
            </sec>
            <sec id="sec014" sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="pone.0267779.s001" position="float" content-type="local-data">
                <label>S1 Table</label>
                <caption>
                  <title>Inclusion and exclusion criteria for each randomized controlled trial included in the pooled analysis.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0267779.s001.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0267779.s002" position="float" content-type="local-data">
                <label>S2 Table</label>
                <caption>
                  <title>Effects of WL and continuous characteristics on means and SDs.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0267779.s002.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>The authors are grateful to the two referees and the editor for their helpful comments and suggestions.</p>
            </ack>
            <ref-list>
              <title>References</title>
              <ref id="pone.0267779.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Clayton</surname><given-names>JA</given-names></name>, <name><surname>Arnegard</surname><given-names>ME</given-names></name>. <article-title>Taking cardiology clinical trials to the next level: A call to action</article-title>. <source><italic toggle="yes">Clin Cardiol</italic></source>. <year>2018</year>;<volume>41</volume>(<issue>2</issue>):<fpage>179</fpage>–<lpage>84</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/clc.22907</pub-id>
<?supplied-pmid 29480590?><pub-id pub-id-type="pmid">29480590</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>Taylor</surname><given-names>AL</given-names></name>, <name><surname>Wright</surname><given-names>JT</given-names><suffix>Jr</suffix></name>, <name><surname>Cooper</surname><given-names>RS</given-names></name>, <etal>et al</etal>. <article-title>Importance of race/ethnicity in clinical trials: Lessons from the african-american heart failure trial (a-heft), the african-american study of kidney disease and hypertension (aask), and the antihypertensive and lipid-lowering treatment to prevent heart attack trial (allhat)</article-title>. <source><italic toggle="yes">Circulation</italic></source>. <year>2005</year>;<volume>112</volume>(<issue>23</issue>):<fpage>3654</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.105.540443</pub-id><?supplied-pmid 16330707?><pub-id pub-id-type="pmid">16330707</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Khoury</surname><given-names>MJ</given-names></name>, <name><surname>Iademarco</surname><given-names>MF</given-names></name>, <name><surname>Riley</surname><given-names>WT</given-names></name>. <article-title>Precision public health for the era of precision medicine</article-title>. <source><italic toggle="yes">Am J Prev Med</italic></source>. <year>2016</year>;<volume>50</volume>(<issue>3</issue>):<fpage>398</fpage>–<lpage>401</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.amepre.2015.08.031</pub-id>
<?supplied-pmid 26547538?><pub-id pub-id-type="pmid">26547538</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Pai</surname><given-names>MP</given-names></name>, <name><surname>Neely</surname><given-names>M</given-names></name>, <name><surname>Rodvold</surname><given-names>KA</given-names></name>, <name><surname>Lodise</surname><given-names>TP</given-names></name>. <article-title>Innovative approaches to optimizing the delivery of vancomycin in individual patients</article-title>. <source><italic toggle="yes">Adv Drug Deliv Rev</italic></source>. <year>2014</year>;<volume>77</volume>:<fpage>50</fpage>–<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.addr.2014.05.016</pub-id>
<?supplied-pmid 24910345?><pub-id pub-id-type="pmid">24910345</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>L</given-names></name>, <name><surname>Manautou</surname><given-names>JE</given-names></name>, <name><surname>Rasmussen</surname><given-names>TP</given-names></name>, <name><surname>Zhong</surname><given-names>XB</given-names></name>. <article-title>Development of precision medicine approaches based on inter-individual variability of bcrp/abcg2</article-title>. <source><italic toggle="yes">Acta Pharm Sin B</italic></source>. <year>2019</year>;<volume>9</volume>(<issue>4</issue>):<fpage>659</fpage>–<lpage>74</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.apsb.2019.01.007</pub-id>
<?supplied-pmid 31384528?><pub-id pub-id-type="pmid">31384528</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Ross</surname><given-names>R</given-names></name>, <name><surname>Goodpaster</surname><given-names>BH</given-names></name>, <name><surname>Koch</surname><given-names>LG</given-names></name>, <etal>et al</etal>. <article-title>Precision exercise medicine: Understanding exercise response variability</article-title>. <source><italic toggle="yes">Br J Sports Med</italic></source>. <year>2019</year>;<volume>53</volume>(<issue>18</issue>):<fpage>1141</fpage>–<lpage>53</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bjsports-2018-100328</pub-id>
<?supplied-pmid 30862704?><pub-id pub-id-type="pmid">30862704</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Whipple</surname><given-names>MO</given-names></name>, <name><surname>Schorr</surname><given-names>EN</given-names></name>, <name><surname>Talley</surname><given-names>KMC</given-names></name>, <name><surname>Lindquist</surname><given-names>R</given-names></name>, <name><surname>Bronas</surname><given-names>UG</given-names></name>, <name><surname>Treat-Jacobson</surname><given-names>D</given-names></name>. <article-title>Variability in individual response to aerobic exercise interventions among older adults</article-title>. <source><italic toggle="yes">J Aging Phys Act</italic></source>. <year>2018</year>;<volume>26</volume>(<issue>4</issue>):<fpage>655</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1123/japa.2017-0054</pub-id><?supplied-pmid 28952853?><pub-id pub-id-type="pmid">28952853</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Martini</surname><given-names>D</given-names></name>, <name><surname>Chiavaroli</surname><given-names>L</given-names></name>, <name><surname>González-Sarrías</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Impact of foods and dietary supplements containing hydroxycinnamic acids on cardiometabolic biomarkers: A systematic review to explore inter-individual variability</article-title>. <source><italic toggle="yes">Nutrients</italic></source>. <year>2019</year>;<volume>11</volume>(<issue>8</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/nu11081805</pub-id><?supplied-pmid 31387247?><pub-id pub-id-type="pmid">31387247</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Menezes</surname><given-names>R</given-names></name>, <name><surname>Rodriguez-Mateos</surname><given-names>A</given-names></name>, <name><surname>Kaltsatou</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Impact of flavonols on cardiometabolic biomarkers: A meta-analysis of randomized controlled human trials to explore the role of inter-individual variability</article-title>. <source><italic toggle="yes">Nutrients</italic></source>. <year>2017</year>;<volume>9</volume>(<issue>2</issue>):<fpage>117</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/nu9020117</pub-id><?supplied-pmid 28208791?><pub-id pub-id-type="pmid">28208791</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Atkinson</surname><given-names>G</given-names></name>, <name><surname>Batterham</surname><given-names>AM</given-names></name>. <article-title>True and false interindividual differences in the physiological response to an intervention</article-title>. <source><italic toggle="yes">Exp Physiol</italic></source>. <year>2015</year>;<volume>100</volume>(<issue>6</issue>):<fpage>577</fpage>–<lpage>88</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1113/EP085070</pub-id>
<?supplied-pmid 25823596?><pub-id pub-id-type="pmid">25823596</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Bonafiglia</surname><given-names>JT</given-names></name>, <name><surname>Brennan</surname><given-names>AM</given-names></name>, <name><surname>Ross</surname><given-names>R</given-names></name>, <name><surname>Gurd</surname><given-names>BJ</given-names></name>. <article-title>An appraisal of the sd(ir) as an estimate of true individual differences in training responsiveness in parallel-arm exercise randomized controlled trials</article-title>. <source><italic toggle="yes">Physiol Rep</italic></source>. <year>2019</year>;<volume>7</volume>(<issue>14</issue>):<fpage>e14163</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.14814/phy2.14163</pub-id><?supplied-pmid 31325240?><pub-id pub-id-type="pmid">31325240</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Shephard</surname><given-names>RJ</given-names></name>, <name><surname>Rankinen</surname><given-names>T</given-names></name>, <name><surname>Bouchard</surname><given-names>C</given-names></name>. <article-title>Test-retest errors and the apparent heterogeneity of training response</article-title>. <source><italic toggle="yes">Eur J Appl Physiol</italic></source>. <year>2004</year>;<volume>91</volume>(<issue>2–3</issue>):<fpage>199</fpage>–<lpage>203</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00421-003-0990-4</pub-id>
<?supplied-pmid 14564526?><pub-id pub-id-type="pmid">14564526</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Dankel</surname><given-names>SJ</given-names></name>, <name><surname>Loenneke</surname><given-names>JP</given-names></name>. <article-title>A method to stop analyzing random error and start analyzing differential responders to exercise</article-title>. <source><italic toggle="yes">Sports Med</italic></source>. <year>2020</year>;<volume>50</volume>(<issue>2</issue>):<fpage>231</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s40279-019-01147-0</pub-id>
<?supplied-pmid 31254258?><pub-id pub-id-type="pmid">31254258</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>Atkinson</surname><given-names>G</given-names></name>, <name><surname>Williamson</surname><given-names>P</given-names></name>, <name><surname>Batterham</surname><given-names>AM</given-names></name>. <article-title>Exercise training response heterogeneity: Statistical insights</article-title>. <source><italic toggle="yes">Diabetologia</italic></source>. <year>2018</year>;<volume>61</volume>(<issue>2</issue>):<fpage>496</fpage>–<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00125-017-4501-2</pub-id>
<?supplied-pmid 29143064?><pub-id pub-id-type="pmid">29143064</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Houston</surname><given-names>DK</given-names></name>, <name><surname>Nicklas</surname><given-names>BJ</given-names></name>, <name><surname>Zizza</surname><given-names>CA</given-names></name>. <article-title>Weighty concerns: The growing prevalence of obesity among older adults</article-title>. <source><italic toggle="yes">J Am Diet Assoc</italic></source>. <year>2009</year>;<volume>109</volume>(<issue>11</issue>):<fpage>1886</fpage>–<lpage>95</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jada.2009.08.014</pub-id>
<?supplied-pmid 19857630?><pub-id pub-id-type="pmid">19857630</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>DiMilia</surname><given-names>PR</given-names></name>, <name><surname>Mittman</surname><given-names>AC</given-names></name>, <name><surname>Batsis</surname><given-names>JA</given-names></name>. <article-title>Benefit-to-risk balance of weight loss interventions in older adults with obesity</article-title>. <source><italic toggle="yes">Curr Diab Rep</italic></source>. <year>2019</year>;<volume>19</volume>(<issue>11</issue>):<fpage>114</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s11892-019-1249-8</pub-id><?supplied-pmid 31686230?><pub-id pub-id-type="pmid">31686230</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Locher</surname><given-names>JL</given-names></name>, <name><surname>Goldsby</surname><given-names>TU</given-names></name>, <name><surname>Goss</surname><given-names>AM</given-names></name>, <name><surname>Kilgore</surname><given-names>ML</given-names></name>, <name><surname>Gower</surname><given-names>B</given-names></name>, <name><surname>Ard</surname><given-names>JD</given-names></name>. <article-title>Calorie restriction in overweight older adults: Do benefits exceed potential risks?</article-title><source><italic toggle="yes">Exp Gerontol</italic></source>. <year>2016</year>;<volume>86</volume>:<fpage>4</fpage>–<lpage>13</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.exger.2016.03.009</pub-id>
<?supplied-pmid 26994938?><pub-id pub-id-type="pmid">26994938</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref018">
                <label>18</label>
                <mixed-citation publication-type="journal"><name><surname>Beavers</surname><given-names>DP</given-names></name>, <name><surname>Beavers</surname><given-names>KM</given-names></name>, <name><surname>Newman</surname><given-names>JJ</given-names></name>, <etal>et al</etal>. <article-title>Heterogeneity of gait speed response to intentional weight loss in older adults</article-title>. <source><italic toggle="yes">Innovation in Aging</italic></source>. <year>2017</year>;<volume>1</volume>(<issue>suppl_1</issue>):<fpage>694</fpage>.</mixed-citation>
              </ref>
              <ref id="pone.0267779.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Kitzman</surname><given-names>DW</given-names></name>, <name><surname>Brubaker</surname><given-names>P</given-names></name>, <name><surname>Morgan</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: A randomized clinical trial</article-title>. <source><italic toggle="yes">JAMA</italic></source>. <year>2016</year>;<volume>315</volume>(<issue>1</issue>):<fpage>36</fpage>–<lpage>46</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jama.2015.17346</pub-id>
<?supplied-pmid 26746456?><pub-id pub-id-type="pmid">26746456</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Messier</surname><given-names>SP</given-names></name>, <name><surname>Loeser</surname><given-names>RF</given-names></name>, <name><surname>Miller</surname><given-names>GD</given-names></name>, <etal>et al</etal>. <article-title>Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: The arthritis, diet, and activity promotion trial</article-title>. <source><italic toggle="yes">Arthritis &amp; Rheumatism</italic></source>. <year>2004</year>;<volume>50</volume>(<issue>5</issue>):<fpage>1501</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">15146420</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref021">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>Messier</surname><given-names>SP</given-names></name>, <name><surname>Mihalko</surname><given-names>SL</given-names></name>, <name><surname>Legault</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: The idea randomized clinical trial</article-title>. <source><italic toggle="yes">JAMA</italic></source>. <year>2013</year>;<volume>310</volume>(<issue>12</issue>):<fpage>1263</fpage>–<lpage>73</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jama.2013.277669</pub-id>
<?supplied-pmid 24065013?><pub-id pub-id-type="pmid">24065013</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Nicklas</surname><given-names>BJ</given-names></name>, <name><surname>Brinkley</surname><given-names>TE</given-names></name>, <name><surname>Houston</surname><given-names>DK</given-names></name>, <etal>et al</etal>. <article-title>Effects of caloric restriction on cardiorespiratory fitness, fatigue, and disability responses to aerobic exercise in older adults with obesity: A randomized controlled trial</article-title>. <source><italic toggle="yes">J Gerontol A Biol Sci Med Sci</italic></source>. <year>2019</year>;<volume>74</volume>(<issue>7</issue>):<fpage>1084</fpage>–<lpage>90</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/gerona/gly159</pub-id>
<?supplied-pmid 29982294?><pub-id pub-id-type="pmid">29982294</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>Nicklas</surname><given-names>BJ</given-names></name>, <name><surname>Chmelo</surname><given-names>E</given-names></name>, <name><surname>Delbono</surname><given-names>O</given-names></name>, <name><surname>Carr</surname><given-names>JJ</given-names></name>, <name><surname>Lyles</surname><given-names>MF</given-names></name>, <name><surname>Marsh</surname><given-names>AP</given-names></name>. <article-title>Effects of resistance training with and without caloric restriction on physical function and mobility in overweight and obese older adults: A randomized controlled trial</article-title>. <source><italic toggle="yes">Am J Clin Nutr</italic></source>. <year>2015</year>;<volume>101</volume>(<issue>5</issue>):<fpage>991</fpage>–<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3945/ajcn.114.105270</pub-id>
<?supplied-pmid 25762810?><pub-id pub-id-type="pmid">25762810</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Normandin</surname><given-names>E</given-names></name>, <name><surname>Yow</surname><given-names>D</given-names></name>, <name><surname>Crotts</surname><given-names>C</given-names></name>, <name><surname>Kiel</surname><given-names>J</given-names></name>, <name><surname>Beavers</surname><given-names>KM</given-names></name>, <name><surname>Nicklas</surname><given-names>BJ</given-names></name>. <article-title>Feasibility of weighted vest use during a dietary weight loss intervention and effects on body composition and physical function in older adults</article-title>. <source><italic toggle="yes">J Frailty Aging</italic></source>. <year>2018</year>;<volume>7</volume>(<issue>3</issue>):<fpage>198</fpage>–<lpage>203</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.14283/jfa.2018.17</pub-id>
<?supplied-pmid 30095153?><pub-id pub-id-type="pmid">30095153</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref025">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Rejeski</surname><given-names>WJ</given-names></name>, <name><surname>Brubaker</surname><given-names>PH</given-names></name>, <name><surname>Goff</surname><given-names>DC</given-names><suffix>Jr.</suffix></name>, <etal>et al</etal>. <article-title>Translating weight loss and physical activity programs into the community to preserve mobility in older, obese adults in poor cardiovascular health</article-title>. <source><italic toggle="yes">Arch Intern Med</italic></source>. <year>2011</year>;<volume>171</volume>(<issue>10</issue>):<fpage>880</fpage>–<lpage>6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/archinternmed.2010.522</pub-id>
<?supplied-pmid 21263080?><pub-id pub-id-type="pmid">21263080</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Beavers</surname><given-names>KM</given-names></name>, <name><surname>Nesbit</surname><given-names>BA</given-names></name>, <name><surname>Kiel</surname><given-names>JR</given-names></name>, <etal>et al</etal>. <article-title>Effect of an energy-restricted, nutritionally complete, higher protein meal plan on body composition and mobility in older adults with obesity: A randomized controlled trial</article-title>. <source><italic toggle="yes">J Gerontol A Biol Sci Med Sci</italic></source>. <year>2019</year>;<volume>74</volume>(<issue>6</issue>):<fpage>929</fpage>–<lpage>35</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/gerona/gly146</pub-id>
<?supplied-pmid 30629126?><pub-id pub-id-type="pmid">30629126</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>Middleton</surname><given-names>A</given-names></name>, <name><surname>Fritz</surname><given-names>SL</given-names></name>, <name><surname>Lusardi</surname><given-names>M</given-names></name>. <article-title>Walking speed: The functional vital sign</article-title>. <source><italic toggle="yes">J Aging Phys Act</italic></source>. <year>2015</year>;<volume>23</volume>(<issue>2</issue>):<fpage>314</fpage>–<lpage>22</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1123/japa.2013-0236</pub-id>
<?supplied-pmid 24812254?><pub-id pub-id-type="pmid">24812254</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Studenski</surname><given-names>S</given-names></name>, <name><surname>Perera</surname><given-names>S</given-names></name>, <name><surname>Patel</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Gait speed and survival in older adults</article-title>. <source><italic toggle="yes">JAMA</italic></source>. <year>2011</year>;<volume>305</volume>(<issue>1</issue>):<fpage>50</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jama.2010.1923</pub-id>
<?supplied-pmid 21205966?><pub-id pub-id-type="pmid">21205966</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Newman</surname><given-names>AB</given-names></name>, <name><surname>Simonsick</surname><given-names>EM</given-names></name>, <name><surname>Naydeck</surname><given-names>BL</given-names></name>, <etal>et al</etal>. <article-title>Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability</article-title>. <source><italic toggle="yes">JAMA</italic></source>. <year>2006</year>;<volume>295</volume>(<issue>17</issue>):<fpage>2018</fpage>–<lpage>26</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jama.295.17.2018</pub-id>
<?supplied-pmid 16670410?><pub-id pub-id-type="pmid">16670410</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref030">
                <label>30</label>
                <mixed-citation publication-type="journal"><article-title>ATS statement: Guidelines for the six-minute walk test</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2002</year>;<volume>166</volume>(<issue>1</issue>):<fpage>111</fpage>–<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1164/ajrccm.166.1.at1102</pub-id>
<?supplied-pmid 12091180?><pub-id pub-id-type="pmid">12091180</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Simonsick</surname><given-names>EM</given-names></name>, <name><surname>Montgomery</surname><given-names>PS</given-names></name>, <name><surname>Newman</surname><given-names>AB</given-names></name>, <name><surname>Bauer</surname><given-names>DC</given-names></name>, <name><surname>Harris</surname><given-names>T</given-names></name>. <article-title>Measuring fitness in healthy older adults: The health abc long distance corridor walk</article-title>. <source><italic toggle="yes">J Am Geriatr Soc</italic></source>. <year>2001</year>;<volume>49</volume>(<issue>11</issue>):<fpage>1544</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1046/j.1532-5415.2001.4911247.x</pub-id>
<?supplied-pmid 11890597?><pub-id pub-id-type="pmid">11890597</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref032">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>Beavers</surname><given-names>KM</given-names></name>, <name><surname>Beavers</surname><given-names>DP</given-names></name>, <name><surname>Newman</surname><given-names>JJ</given-names></name>, <etal>et al</etal>. <article-title>Effects of total and regional fat loss on plasma crp and il-6 in overweight and obese, older adults with knee osteoarthritis</article-title>. <source><italic toggle="yes">Osteoarthritis Cartilage</italic></source>. <year>2015</year>;<volume>23</volume>(<issue>2</issue>):<fpage>249</fpage>–<lpage>56</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.joca.2014.11.005</pub-id>
<?supplied-pmid 25450847?><pub-id pub-id-type="pmid">25450847</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref033">
                <label>33</label>
                <mixed-citation publication-type="journal"><name><surname>Ferrucci</surname><given-names>L</given-names></name>, <name><surname>Harris</surname><given-names>TB</given-names></name>, <name><surname>Guralnik</surname><given-names>JM</given-names></name>, <etal>et al</etal>. <article-title>Serum IL-6 level and the development of disability in older persons</article-title>. <source><italic toggle="yes">J Am Geriatr Soc</italic></source>. <year>1999</year>;<volume>47</volume>(<issue>6</issue>):<fpage>639</fpage>–<lpage>46</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1532-5415.1999.tb01583.x</pub-id>
<?supplied-pmid 10366160?><pub-id pub-id-type="pmid">10366160</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref034">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>Ridker</surname><given-names>PM</given-names></name>. <article-title>C-reactive protein, inflammation, and cardiovascular disease: Clinical update</article-title>. <source><italic toggle="yes">Tex Heart Inst J</italic></source>. <year>2005</year>;<volume>32</volume>(<issue>3</issue>):<fpage>384</fpage>–<lpage>6</lpage>. <?supplied-pmid 16392225?><pub-id pub-id-type="pmid">16392225</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref035">
                <label>35</label>
                <mixed-citation publication-type="journal"><name><surname>Studenski</surname><given-names>S</given-names></name>, <name><surname>Perera</surname><given-names>S</given-names></name>, <name><surname>Patel</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Gait speed and survival in older adults</article-title>. <source><italic toggle="yes">JAMA</italic></source>. <year>2011</year>;<volume>305</volume>(<issue>1</issue>):<fpage>50</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jama.2010.1923</pub-id>
<?supplied-pmid 21205966?><pub-id pub-id-type="pmid">21205966</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref036">
                <label>36</label>
                <mixed-citation publication-type="journal"><name><surname>Peel</surname><given-names>NM</given-names></name>, <name><surname>Kuys</surname><given-names>SS</given-names></name>, <name><surname>Klein</surname><given-names>K</given-names></name>. <article-title>Gait speed as a measure in geriatric assessment in clinical settings: A systematic review</article-title>. <source><italic toggle="yes">J Gerontol A Biol Sci Med Sci</italic></source>. <year>2012</year>;<volume>68</volume>(<issue>1</issue>):<fpage>39</fpage>–<lpage>46</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/gerona/gls174</pub-id>
<?supplied-pmid 22923430?><pub-id pub-id-type="pmid">22923430</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref037">
                <label>37</label>
                <mixed-citation publication-type="journal"><name><surname>Fantuzzi</surname><given-names>G.</given-names></name><article-title>Adipose tissue, adipokines, and inflammation</article-title>. <source><italic toggle="yes">J Allergy Clin Immunol</italic></source>. <year>2005</year>;<volume>115</volume>(<issue>5</issue>):<fpage>911</fpage>–<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jaci.2005.02.023</pub-id>
<?supplied-pmid 15867843?><pub-id pub-id-type="pmid">15867843</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref038">
                <label>38</label>
                <mixed-citation publication-type="journal"><name><surname>Pahor</surname><given-names>M</given-names></name>, <name><surname>Kritchevsky</surname><given-names>S</given-names></name>. <article-title>Research hypotheses on muscle wasting, aging, loss of function and disability</article-title>. <source><italic toggle="yes">J Nutr Health Aging</italic></source>. <year>1998</year>;<volume>2</volume>(<issue>2</issue>):<fpage>97</fpage>–<lpage>100</lpage>. <?supplied-pmid 10993575?><pub-id pub-id-type="pmid">10993575</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref039">
                <label>39</label>
                <mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>S</given-names></name>, <name><surname>Leng</surname><given-names>XI</given-names></name>, <name><surname>Kritchevsky</surname><given-names>SB</given-names></name>. <article-title>Body composition and physical function in older adults with various comorbidities</article-title>. <source><italic toggle="yes">Innov Aging</italic></source>. <year>2017</year>;<volume>1</volume>(<issue>1</issue>):<fpage>igx008</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/geroni/igx008</pub-id><?supplied-pmid 30480107?><pub-id pub-id-type="pmid">30480107</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref040">
                <label>40</label>
                <mixed-citation publication-type="journal"><name><surname>You</surname><given-names>T</given-names></name>, <name><surname>Nicklas</surname><given-names>BJ</given-names></name>. <article-title>Chronic inflammation: Role of adipose tissue and modulation by weight loss</article-title>. <source><italic toggle="yes">Curr Diabetes Rev</italic></source>. <year>2006</year>;<volume>2</volume>(<issue>1</issue>):<fpage>29</fpage>–<lpage>37</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2174/157339906775473626</pub-id>
<?supplied-pmid 18220615?><pub-id pub-id-type="pmid">18220615</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref041">
                <label>41</label>
                <mixed-citation publication-type="journal"><name><surname>Hortobágyi</surname><given-names>T</given-names></name>, <name><surname>Lesinski</surname><given-names>M</given-names></name>, <name><surname>Gäbler</surname><given-names>M</given-names></name>, <name><surname>Van Swearingen</surname><given-names>JM</given-names></name>, <name><surname>Malatesta</surname><given-names>D</given-names></name>, <name><surname>Granacher</surname><given-names>U</given-names></name>. <article-title>Effects of three types of exercise interventions on healthy old adults’ gait speed: A systematic review and meta-analysis</article-title>. <source><italic toggle="yes">Sports medicine</italic></source>. <year>2015</year>;<volume>45</volume>(<issue>12</issue>):<fpage>1627</fpage>–<lpage>43</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s40279-015-0371-2</pub-id>
<?supplied-pmid 26286449?><pub-id pub-id-type="pmid">26286449</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref042">
                <label>42</label>
                <mixed-citation publication-type="journal"><name><surname>Pahor</surname><given-names>M</given-names></name>, <name><surname>Guralnik</surname><given-names>JM</given-names></name>, <name><surname>Ambrosius</surname><given-names>WT</given-names></name>, <name><surname>Blair</surname><given-names>S</given-names></name>, <name><surname>Bonds</surname><given-names>DE</given-names></name>, <name><surname>Church</surname><given-names>TS</given-names></name>, <etal>et al</etal>. <article-title>Effect of structured physical activity on prevention of major mobility disability in older adults: The life study randomized clinical trial</article-title>. <source><italic toggle="yes">JAMA</italic></source>. <year>2014</year>;<volume>311</volume>(<issue>23</issue>):<fpage>2387</fpage>–<lpage>96</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jama.2014.5616</pub-id>
<?supplied-pmid 24866862?><pub-id pub-id-type="pmid">24866862</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref043">
                <label>43</label>
                <mixed-citation publication-type="journal"><name><surname>Chaston</surname><given-names>TB</given-names></name>, <name><surname>Dixon</surname><given-names>JB</given-names></name>, <name><surname>O’Brien</surname><given-names>PE</given-names></name>. <article-title>Changes in fat-free mass during significant weight loss: A systematic review</article-title>. <source><italic toggle="yes">Int J Obes (Lond)</italic></source>. <year>2007</year>;<volume>31</volume>(<issue>5</issue>):<fpage>743</fpage>–<lpage>50</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/sj.ijo.0803483</pub-id>
<?supplied-pmid 17075583?><pub-id pub-id-type="pmid">17075583</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref044">
                <label>44</label>
                <mixed-citation publication-type="journal"><name><surname>Perera</surname><given-names>S</given-names></name>, <name><surname>Mody</surname><given-names>SH</given-names></name>, <name><surname>Woodman</surname><given-names>RC</given-names></name>, <name><surname>Studenski</surname><given-names>SA</given-names></name>. <article-title>Meaningful change and responsiveness in common physical performance measures in older adults</article-title>. <source><italic toggle="yes">J Gerontol A Biol Sci Med Sci</italic></source>. <year>2006</year>;<volume>54</volume>(<issue>5</issue>):<fpage>743</fpage>–<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1532-5415.2006.00701.x</pub-id>
<?supplied-pmid 16696738?><pub-id pub-id-type="pmid">16696738</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0267779.ref045">
                <label>45</label>
                <mixed-citation publication-type="journal"><name><surname>Royston</surname><given-names>P</given-names></name>, <name><surname>Altman</surname><given-names>DG</given-names></name>, <name><surname>Sauerbrei</surname><given-names>W</given-names></name>. <article-title>Dichotomizing continuous predictors in multiple regression: A bad idea</article-title>. <source>Stat Med</source>. <year>2006</year>;<volume>25</volume>(<issue>1</issue>):<fpage>127</fpage>–<lpage>41</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/sim.2331</pub-id>
<?supplied-pmid 16217841?><pub-id pub-id-type="pmid">16217841</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
